Vein of Marshall Ethanol Infusion Related Lesion Durability: Looking for the Real Scar. Center‐Cluster, Case‐Control Study
Pacing and Clinical Electrophysiology · 2025
DOI: 10.1111/pace.70072 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pacing and Clinical Electrophysiology, 2025. Verfasst von Procolo Marchese und 15 weiteren Autor:innen. Beteiligte Einrichtung: Electrophysiology Unit, Cardiology Department, AST, Ascoli Piceno, Italy. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Cicatrix, Ethanol. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Introduction
Vein of Marshall ethanol infusion (VOM‐EI) in patients with Atrial Fibrillation (AFib) triggers local injury, which may increase the subsequent radiofrequency catheter ablation (RFCA) success rate in persistent atrial fibrillation (PeAF). The long‐term durability of VOM‐EI induced low‐voltage area (LVA), might condition the success of RFCA after VOM‐EI. We hypothesized that the amount of LVA after VOM‐EI decreases over time.
Methods
Consecutive patients with recurrent PeAF and no history of previous ablation were enrolled in this prospective, center‐cluster, case‐control study. In the experimental group, RFCA was performed 1 month after VOM‐EI. In the control group, VOM‐EI and RFCA were performed concomitantly. The primary endpoint was the bipolar VOM‐EI LVA measured immediately prior to RFCA.
Results
We studied 80 consecutive patients who met the inclusion criteria. The two groups did not differ in baseline characteristics. The mean bipolar VOM‐EI‐LVA measured before RFCA was significantly smaller in the 40 patients who underwent VOM‐EI 1 month earlier than in the group of 40 patients who underwent the standard procedure (2.6 ± 2.4 vs. 10.0 ± 7.0 cm 2 , p = 0.012). At a mean follow‐up of 19.6 ± 7.3 months, freedom from AF/AT recurrences was promisingly higher in the investigational group compared to the control group (90.0% vs. 82.5%).
Conclusion
These data suggest that the endocardial newly‐formed lesion induced by VOM‐EI decreases over time, probably due to progressive resolution of perilesional oedema. These results merit larger studies testing the hypothesis that postponing RFCA 1 month after VOM‐EI may increase its effectiveness in terms of fewer recurrences of atrial fibrillation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Electrophysiology Unit, Cardiology Department, AST, Ascoli Piceno, Italy.
- Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy.
- Interventional Electrophysiology Division, Fondazione Toscana "Gabriele Monasterio", Pisa, Italy.
ORCID-Profile: Procolo Marchese, Luigi Cocchiara
Zitieren
APA
Marchese, P., Gennaro, F., Mazzotta, G., Grossi, P., Cocchiara, L., Brescia, B., Mirarchi, M., Eddine, K. S., Zaurino, N., Nesti, M., Mirizzi, G., Garibaldi, S., Panchetti, L., Startari, U., Piacenti, M., & Rossi, A. (2025). Vein of Marshall Ethanol Infusion Related Lesion Durability: Looking for the Real Scar. Center‐Cluster, Case‐Control Study. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70072
Vancouver
Marchese P, Gennaro F, Mazzotta G, Grossi P, Cocchiara L, Brescia B, et al. Vein of Marshall Ethanol Infusion Related Lesion Durability: Looking for the Real Scar. Center‐Cluster, Case‐Control Study. Pacing and Clinical Electrophysiology. 2025. doi:10.1111/pace.70072
BibTeX
@article{Marchese2025,
author = {Marchese, Procolo and Gennaro, Francesca and Mazzotta, Giovanni and Grossi, Pierfrancesco and Cocchiara, Luigi and Brescia, Benedetta and Mirarchi, Matteo and Eddine, Karim Shehab and Zaurino, Nicola and Nesti, Martina and Mirizzi, Gianluca and Garibaldi, Silvia and Panchetti, Luca and Startari, Umberto and Piacenti, Marcello and Rossi, Andrea},
title = {Vein of Marshall Ethanol Infusion Related Lesion Durability: Looking for the Real Scar. Center‐Cluster, Case‐Control Study},
journal = {Pacing and Clinical Electrophysiology},
year = {2025},
doi = {10.1111/pace.70072}
}
EUVIMED